These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24349260)

  • 1. Opposing roles of PKA and EPAC in the cAMP-dependent regulation of schwann cell proliferation and differentiation [corrected].
    Bacallao K; Monje PV
    PLoS One; 2013; 8(12):e82354. PubMed ID: 24349260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of cAMP signaling for Schwann cell differentiation restricts the onset of myelination.
    Bacallao K; Monje PV
    PLoS One; 2015; 10(2):e0116948. PubMed ID: 25705874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exchange proteins directly activated by cAMP induce the proliferation of rat anterior pituitary GH3 cells via the activation of extracellular signal-regulated kinase.
    Sun W; Jiao W; Huang Y; Li R; Zhang Z; Wang J; Lei T
    Biochem Biophys Res Commun; 2017 Apr; 485(2):355-359. PubMed ID: 28216156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation.
    Mei FC; Qiao J; Tsygankova OM; Meinkoth JL; Quilliam LA; Cheng X
    J Biol Chem; 2002 Mar; 277(13):11497-504. PubMed ID: 11801596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation.
    Monje PV; Athauda G; Wood PM
    J Biol Chem; 2008 Dec; 283(49):34087-100. PubMed ID: 18799465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
    Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
    Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium Reversibly Inhibits Schwann Cell Proliferation and Differentiation Without Inducing Myelin Loss.
    Piñero G; Berg R; Andersen ND; Setton-Avruj P; Monje PV
    Mol Neurobiol; 2017 Dec; 54(10):8287-8307. PubMed ID: 27917448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.
    Howe DG; McCarthy KD
    J Neurosci; 2000 May; 20(10):3513-21. PubMed ID: 10804191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis.
    Hochbaum D; Hong K; Barila G; Ribeiro-Neto F; Altschuler DL
    J Biol Chem; 2008 Feb; 283(8):4464-8. PubMed ID: 18063584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-dependent protein kinase and Epac mediate cyclic AMP responses in pancreatic acini.
    Chaudhuri A; Husain SZ; Kolodecik TR; Grant WM; Gorelick FS
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1403-10. PubMed ID: 17234888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
    Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon contact-driven Schwann cell dedifferentiation.
    Soto J; Monje PV
    Glia; 2017 Jun; 65(6):864-882. PubMed ID: 28233923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
    Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
    J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.
    Garay J; D'Angelo JA; Park Y; Summa CM; Aiken ML; Morales E; Badizadegan K; Fiebiger E; Dickinson BL
    J Immunol; 2010 Sep; 185(6):3227-38. PubMed ID: 20729327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.
    Kiermayer S; Biondi RM; Imig J; Plotz G; Haupenthal J; Zeuzem S; Piiper A
    Mol Biol Cell; 2005 Dec; 16(12):5639-48. PubMed ID: 16207818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
    Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
    PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and Functional Characteristics of Human Schwann Cells as Revealed by Cell-Based Assays and RNA-SEQ.
    Monje PV; Sant D; Wang G
    Mol Neurobiol; 2018 Aug; 55(8):6637-6660. PubMed ID: 29327207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
    Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
    Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac.
    Khaliulin I; Bond M; James AF; Dyar Z; Amini R; Johnson JL; Suleiman MS
    Br J Pharmacol; 2017 Mar; 174(6):438-453. PubMed ID: 28071786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production.
    García-Morales V; Cuíñas A; Elíes J; Campos-Toimil M
    Vascul Pharmacol; 2014 Mar; 60(3):95-101. PubMed ID: 24469067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.